FLJ13611 activators refer to a class of chemical compounds that modulate the activity of the protein encoded by the FLJ13611 gene. While the exact function of this protein is not fully characterized, it is known that such activators can influence its biological activity. The protein may be involved in various cellular processes, and the activators work by binding to it and affecting its function. This can be achieved through a direct interaction with the protein, thereby increasing its intrinsic activity, or by stabilizing the protein in a conformation that is more active or capable of interacting with other cellular components more effectively. The activators of FLJ13611 are typically small molecules that can traverse cell membranes to engage with their intracellular target.
The structural diversity of FLJ13611 activators is indicative of the multiple pathways through which they can enhance the biological activity of the FLJ13611 protein. The complexity of these molecules ranges from simple, organic structures to more elaborate, multi-ringed systems, allowing for various points of interaction with the protein. The binding sites on the protein for these activators may be located at various positions, including allosteric sites or the active site, and the binding can lead to a change in the protein's activity. The binding affinity and specificity of FLJ13611 activators are determined by the chemistry of the activator and the structural complementarity to the protein target. Chemical interactions such as ionic bonds, pi-pi stacking, and hydrogen bonds may play a role in the stability and efficacy of these interactions, affecting the way the activator modulates the protein's function at the molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
Affects vesicle transport, potentially altering the dynamics where TRAPPC13 is active. | ||||||
Nigericin sodium salt | 28643-80-3 | sc-201518A sc-201518 sc-201518B sc-201518C sc-201518D | 1 mg 5 mg 25 mg 1 g 5 g | $45.00 $110.00 $235.00 $6940.00 $26879.00 | 9 | |
Influences ion gradients that are crucial for vesicle formation and transport. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Induces cAMP production which can impact vesicular transport and indirectly affect TRAPPC13. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Alters calcium storage in the ER, potentially influencing vesicle transport. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Inhibits N-linked glycosylation in the ER and can impact vesicular pathways. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $187.00 $670.00 | 11 | |
Targets ARF GEFs which modulate vesicle formation and might indirectly influence TRAPPC13. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Affects endosomal acidification, which might indirectly modulate TRAPPC13's role in transport. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Known to influence multiple cellular pathways including vesicular transport. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $273.00 | 6 | |
Impairs ARF GTPase activation which can alter vesicle dynamics. | ||||||
Progesterone | 57-83-0 | sc-296138A sc-296138 sc-296138B | 1 g 5 g 50 g | $20.00 $51.00 $292.00 | 3 | |
Can affect vesicular transport and may thus indirectly modulate TRAPPC13 function. | ||||||